Merger

Livers Bronze and DeAngelis Iron Work are merging, but this is no typical consolidation. It’s a strategic alignment of heritage and ambition. What does it signal?

Backed by private equity, RMH Systems' acquisition of Systems in Motion creates a national automation giant, merging factory and warehouse solutions.

LXP Industrial Trust's era as a public REIT ends in a $5.2B acquisition, a deal that signals institutional investors' relentless pursuit of Class A warehouses.

Reseda Group's strategic investment in Stickley on Security aims to democratize enterprise-grade cybersecurity for credit unions of all sizes.

Finward Bancorp's Q2 results show solid loan growth but a spike in non-performing loans, as the bank prepares for a strategic merger with First Financial.

While broader healthcare dealmaking slows, a perfect storm of fresh private equity capital and new regulations is making dermatology a hotbed of investment.

Pacific West Bancorp posts impressive growth in its final earnings report, closing a 22-year chapter. We dissect the numbers and the strategy behind its merger with 1st Security Bank.

A sharp 26% drop in Medical Outpatient Building M&A reveals a market grappling with high interest rates, but strategic acquirers still find opportunity.

By selling its mass cytometry unit and securing a $30M payout, Standard BioTools is fortifying its balance sheet for a transformative merger with Treeline.

Red Oak and MirrorWeb's merger isn't just a tech deal; it's a new blueprint for finance, turning rigid compliance into a dynamic catalyst for growth.

Slovakian battery innovator InoBat is going public via a SPAC deal, aiming its advanced energy storage at the insatiable power demands of AI and data centers.

Following a strategic merger and a $200M financing round, Yarrow Bioscience is advancing a novel drug for autoimmune thyroid disease. But can it disrupt a market dominated by incumbents?

A landmark merger between France's ARGAN and Belgium's WDP creates a new logistics titan. We explore the deal's mechanics and its ripple effects.

A struggling medical AI firm plans a merger with a crypto miner. Is this a desperate act or a brilliant new model for funding deep tech innovation in 2026?

Union Pacific's merger with Norfolk Southern hinges on a deal with CN. This isn't just a corporate handshake; it's a strategic gambit that will redefine competition in the Midwest.

Strong Q2 earnings and merger progress paint a rosy picture for Colony Bank. But beneath the surface, declining deposits and rising credit costs reveal the risks.

CO2 Energy Transition Corp. wins more time for its energy deal, but a tight redemption deadline and a tough market raise the stakes for its ambitious plan.

As private equity reshapes healthcare with a focus on short-term returns, one family-owned firm bets its future on a different model: decades-long trust.

With a new CEO famed for a $2.4B exit and a reverse merger in play, Mentari Therapeutics isn't just developing drugs; it's building a powerhouse.

A struggling medtech firm and an AI drug developer merge. It's not just a deal; it's a new blueprint for innovation, funded by high-risk capital.